Methods of Labor Induction and Perinatal Outcomes (MEDIP)

November 17, 2025 updated by: Assistance Publique - Hôpitaux de Paris

Methods of Labor Induction and Perinatal Outcomes : a Prospective National Study in France

Since it is a frequent intervention in Obstetrics, labor induction is rarely evaluated from national population-based cohorts. The study aims to assess the frequency of different induction methods used in France from a prospective population-based cohort of women with an induced labor. Maternal, fetal and neonatal outcomes will be compared between the different induction methods. Moreover the adhesion to national clinical guidelines concerning the induction of labor will be studied from this population-based cohort.

Finally the women satisfaction will be assessed according to the induction method used.

Study Overview

Status

Completed

Conditions

Detailed Description

Labor induction concerns about 22% of deliveries in France, according to the the 2010 French national perinatal survey. Labor induction could be associated with a higher risk of fetal and maternal complications, justifying its assessment from a population-based prospective cohort.

Several methods (dinoprostone, oxytocin, misoprostol, balloon catheter …) are used to induce labor in France. To decide and perform labor inductions, physicians can refer to published guidelines according to specific obstetrical situations. But many of these guidelines are based on a low level of evidence probably explaining observed differences in practices.

In some cases, labor induction is decided without indication, and women's involvement in this kind of decisions is not really evaluated.

The objectives are therefore :

  • To evaluate the frequency of use of different methods for labor induction according to the cervix status, the indication of labor induction, and the place of the delivery.
  • To analyse maternal, fetal and neonatal issues according to the different induction methods, taken into account the induction indications
  • To compare current practices of labor induction to published national guidelines and to assess the impact of deviations from these guidelines on maternal and neonatal issues
  • To assess women's satisfaction regarding the indication and the induction method used.

Study Type

Observational

Enrollment (Actual)

3049

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Paris, France, 75014
        • Port-Royal maternity unit, Cochin Hospital, Assistance publique des Hôpitaux de Paris (APHP

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

all women who have an induced labor

Description

Inclusion Criteria:

  • patient who has a labor induction
  • with a live fetus at the beginning of induction
  • patient who did not have any opposition to use her medical and personal data or her child's medical data for research

Exclusion Criteria:

  • in utero fetal death
  • termination of pregnancy
  • patient's refusal to participate to the study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
all women with an induced labor
prospective population-based cohort of all women who have an induced labor during one month in seven perinatal networks
all women who have an induced labor

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Composite measure of induction methods
Time Frame: Beginning of labor induction
  • Amniotomy
  • Amniotomy and oxytocin
  • Prostaglandins (PGE1, PGE2)
  • Balloon catheter

For each of these methods, evaluation of these composite criteria

  • Frequency
  • Posology
  • Way of administration
  • Indication of labor induction
Beginning of labor induction

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Composite measure of maternal morbidity
Time Frame: Labor induction
  • Systemic infection
  • Uterine hyperkinesia
  • Uterine hypertonia
  • Instrumental delivery
  • Caesarean section
  • Degrees of perineal lacerations
  • Surgical complications
  • Uterine rupture
  • Manual removal of the placenta
  • Postpartum haemorrhage
  • Anaemia
  • Maternal transfer in ICU
Labor induction
Composite measure of fetal and neonatal mortality and morbidity
Time Frame: from induction up to average 7 days post delivery
  • Fetal heart rate anomalies during labor
  • Apgar score
  • Acidosis (pH < 7.10)
  • Intubation
  • Surfactant treatment administration
  • Non-invasive ventilation
  • Cardiopulmonary resuscitation
  • Adrenaline administration
  • Neonatal mortality
  • Neonatal trauma (fracture of long bones or skull, brachial plexus elongation, injury of the spinal cord, subdural hematoma)
  • Neonatal transfer in ICU
from induction up to average 7 days post delivery
Women's satisfaction Questionnaire
Time Frame: 8 weeks after delivery

18 questions about :

  • Woman's implication in the decision of labor induction
  • Woman's comprehension about the reason of labor induction
  • Woman's satisfaction about the decision/labor/delivery
8 weeks after delivery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Camille Le Ray, Assistance Publique des Hôpitaux de Paris (APHP)
  • Study Director: François Goffinet, Assistance Publique des Hôpitaux de Paris (APHP)

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

November 1, 2015

Primary Completion (Actual)

September 1, 2016

Study Completion (Actual)

December 1, 2016

Study Registration Dates

First Submitted

June 10, 2015

First Submitted That Met QC Criteria

June 19, 2015

First Posted (Estimated)

June 22, 2015

Study Record Updates

Last Update Posted (Actual)

November 20, 2025

Last Update Submitted That Met QC Criteria

November 17, 2025

Last Verified

October 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • AAP-2014-030

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Induction of Labor

Clinical Trials on all women with an induced labor

Subscribe